Table 2.
Kaplan-Meier survival analysis of SOC patients.
| Parameter | Patients (n=104) | OS (months) Mean ±S.D. | 5-year OS | P value |
|---|---|---|---|---|
| Age (years) | ||||
| ≤54.0 | 55 | 86.6±5.7 | 82.6% | 0.459 |
| >54.0 | 49 | 90.5±5.7 | 92.1% | |
| CA-125 (U/ml) | ||||
| ≤554.0 | 50 | 92.9±5.3 | 90.1% | 0.240 |
| >554.0 | 54 | 84.8±5.5 | 84.6% | |
| Differentiation | ||||
| Well/moderate | 58 | 100.4±4.8 | 94.5% | 0.002* |
| Poor | 46 | 74.5±5.9 | 77.5% | |
| LN metastasis | ||||
| Negative | 64 | 97.4±4.3 | 93.1% | 0.002* |
| Positive | 40 | 69.3±5.4 | 76.4% | |
| FIGO stage | ||||
| I–II | 47 | 103.7±4.4 | 100.0% | <0.001* |
| III–IV | 57 | 71.6±4.1 | 74.8% | |
| PATZ1 expression | ||||
| Low | 41 | 65.9±5.0 | 68.1% | 0.002* |
| High | 63 | 93.7±4.2 | 92.9% | |
OS – overall survival; LN – lymph node; FIGO – International Federation of Gynecology and Obstetrics.